RBC Disruptors - The Vancouver biotech company on a mission to help the world

Jun 23, 2021 | Brian Moore


Share

As Canada emerges from the COVID-19 pandemic, thanks in large part to the lightning-fast development of new vaccines, medical innovation has never been more fascinating—or more critical.

RBC Disruptors Series Podcast

Biotech has quickly become one of the most important emerging sectors in the Canadian economy. Today, Canada’s 10 largest biotech companies have a combined market cap of $28 billion. Topping the list is Vancouver-based AbCellera Biologics, which debuted on the NASDAQ Stock Exchange with a record-breaking IPO late last year—making it Canada’s most valuable biotech company in history.

 

Click here for the full podcast; RBC Disruptors Series.